losartan potassium + Comparator: Placebo

ApprovedCompleted
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

High Blood Pressure

Conditions

High Blood Pressure

Trial Timeline

Mar 14, 2000 → Jan 1, 2005

About losartan potassium + Comparator: Placebo

losartan potassium + Comparator: Placebo is a approved stage product being developed by Organon for High Blood Pressure. The current trial status is completed. This product is registered under clinical trial identifier NCT00140907. Target conditions include High Blood Pressure.

What happened to similar drugs?

3 of 20 similar drugs in High Blood Pressure were approved

Approved (3) Terminated (6) Active (12)
Edoxaban + ASADaiichi SankyoPhase 3
🔄SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
🔄SHR3680 + PlaceboJiangsu Hengrui MedicinePhase 3
HHPG-19K InjectionJiangsu Hengrui MedicinePhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00140907ApprovedCompleted

Competing Products

20 competing products in High Blood Pressure

See all competitors
ProductCompanyStageHype Score
azenosertibZentalis PharmaceuticalsPhase 2
32
GTB-3550 TriKE® Phase I + GTB-3550 TriKE® Phase IIGT BiopharmaPhase 1/2
14
Sepantronium BromideCothera BiosciencePhase 2
29
Edoxaban + ASADaiichi SankyoPhase 3
32
olanzapine plus fosaprepitant-based triple regimen + placebo plus fosaprepitant-based triple regimenSun PharmaceuticalPhase 3
36
Bunazosin + Doxazosin + ValsartinEisaiApproved
43
Pembrolizumab + Pemetrexed + AbemaciclibEli LillyPhase 1
21
DSP-0390Sumitomo PharmaPhase 1
33
dalpiciclib isethionate tablets; abiraterone acetate tablets; prednisone tablets + placebo; abiraterone acetate tablets; prednisone tabletsJiangsu Hengrui MedicinePhase 1
36
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
44
SHR3680 + PlaceboJiangsu Hengrui MedicinePhase 3
47
Camrelizumab、Rivoceranib + CamrelizumabJiangsu Hengrui MedicinePhase 2
35
Mirvetuximab soravtansine + CarboplatinAbbViePhase 2
39
HHPG-19K InjectionJiangsu Hengrui MedicinePhase 3
32
Mirvetuximab SoravtansineAbbViePhase 2
42
Zibotentan/Dapagliflozin + DapagliflozinAstraZenecaPhase 2
42
AZD5718 IR tablet + AZD5718 oral suspension + Rosuvastatin tabletAstraZenecaPhase 1
29
Metoprolol Succinate + HydrochlorothiazideAstraZenecaPhase 3
40
Olaparib Pill + AZD6738AstraZenecaPhase 2
35
DAPA/MET XR + DAPA + MET XRAstraZenecaPhase 3
40